Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

Fresh Angles On Display In ERISA Summer Filing Uptick No Photo Available

Kellie Mejdrich

Attorneys dealing with a rise in Employee Retirement Income Security Act cases are paying close attention to a handful of recent suits... (more story)

BRG Directors On The State Of Tariffs And Hospitals No Photo Available

Yeji Jesse Lee

The impact of Trump administration tariffs on hospitals is beginning to show up on invoices and in vendor contracts, even as the full ... (more story)

Particle's Antitrust Battle With Epic: 3 Things To Know No Photo Available

Mark Payne

Epic Systems Corp. must face allegations it violated federal law by attempting to monopolize a segment of the electronic health record... (more story)